Hop Sanderson Tran Cao

Statistics

Publications

Citations

344

H-Index

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hop Sanderson Tran Cao is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2020–2022

Publications

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao et al. · The Lancet. Gastroenterology & hepatology · 2022 · 256 citations · Full text

Pharmacy, Oncology, Perioperative Medicine +15

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma

Gohar Manzar, Brian De, Chike O. Abana et al. · Cancers · 2022 · 32 citations · Full text

Pharmacy, Oncology, Radiation Oncology +16

Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.

Ahmed O. Kaseb, Dan G. Duda, Hop Sanderson Tran Cao et al. · Journal of Clinical Oncology · 2020 · 28 citations

Life Sciences, Oncology, Surgery +17

Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.

Ahmed O. Kaseb, Hop Sanderson Tran Cao, Yehia I. Mohamed et al. · Journal of Clinical Oncology · 2020 · 28 citations

Pharmacy, Oncology, Surgery +16

1–4 of 4